pubs.acs.org/joc
activities.3 The studies on biological activities of 6-arylpurines
Direct Synthesis of 6-Arylpurines by Reaction of
6-Chloropurines with Activated Aromatics
have been limited to easily available purines bearing simple
aryl groups, while those bearing highly substituted and/or
functionalized aryl moieties remain to be explored.4
Hai-Ming Guo,*,† Pu Li,† Hong-Ying Niu,‡
Dong-Chao Wang,† and Gui-Rong Qu*,†
The classical methods for the synthesis of 6-arylpurines
involve the cross-coupling reactions of aryl organometallics
(Ar-M) and 6-halopurines (Scheme 1, eq 1) or aryl halides
(Ar-X) and 6-metalpurines5 (Scheme 1, eq 2). For example,
Suzuki-Miyaura,3a,6 Stille,7 Negishi,7a,8 and Kumada coup-
ling reactions9 have been commonly applied to the prepara-
tion of 6-arylpurines. Though significant attention has been
received over the last several years, these cross-coupling re-
actions usually involve the following aspects: (a) expensive
palladium, nickel, and complex ligands are employed as cata-
lysis systems; (b) the preparation of organometallic re-
agents is usually conducted under rigorous reaction condi-
tions (anhydrous, nitrogen atmosphere); (c) the reaction
with metallic reagents usually requires multistep including
protection of the sensitive functional groups (such as hydro-
xyl, amino, or imino group) in the substrates if necessary.
This generates byproducts and wastes from reagents, sol-
vents, and purification. Therefore, it is still of great impor-
tance to develop alternative methods for the preparation of
6-arylpurines. Herein, we will report direct arylation of
6-chloropurine with arenes promoted by anhydrous AlCl3
for the synthesis of highly functionalized C6-aryl-substituted
purine analogues.
†College of Chemistry and Environmental Science,
Key Laboratory of Green Chemical Media and Reactions of
Ministry of Education, Henan Normal University, Xinxiang
453007, Henan, China, and ‡School of Chemistry and
Chemical Engineering, Henan Institute of Science and
Technology, Xinxiang 453003, China
ghm@htu.cn; quguir@sina.com.cn
Received May 26, 2010
During the ongoing course of our study on the develop-
ment of new methods for the synthesis of nucleoside ana-
logues10 and according to reports on arylation and hetero-
arylation of heterocyclic systems,11 we had predicted that
C6-aryl-substituted purine analogues could be synthesized
Highly functionalized C6-aryl-substituted purine ana-
logues were synthesized through direct arylation of 6-chloro-
purine with aromatics promoted by anhydrous AlCl3 in a
single step. The reactions, which were conducted using a
3-fold excess of AlCl3 in refluxing 1,2-dichloroethane,
gave moderate to excellent product yields in 0.5 h. This
work is complementary to the classical coupling re-
actions for the synthesis of C6-aryl-substituted purine
analogues.
ꢁ
ꢀ
(4) Turek, P.; Kotora, M.; Hocek, M.; Cısarova, I. Tetrahetron. Lett.
2003, 44, 785.
(5) Prasad, A. S. B.; Stevenson, T. M.; Citineni, J. R.; Nyzam, V.;
Knochel, P. Tetrahetron 1997, 53, 7237.
(6) (a) Lakshman, M. K.; Hilmer, J. H.; Martin, J. Q.; Keeler, J. C.; Dinh,
Y. Q. V.; Ngassa, F. N.; Russon, L. M. J. Am. Chem. Soc. 2001, 123, 7779.
ꢁ
ꢁ
ꢀꢁ ꢀ
(b) Cerna, I.; Pohl, R.; Klepetarova, B.; Hocek, M. J. Org. Chem. 2008, 73,
9048. (c) Lakshman, M. K.; Thomson, P. F.; Nuqui, M. A.; Hilmer, J. H.;
Sevova, N.; Boggess, B. Org. Lett. 2002, 4, 1479. (d) Gunda, P.; Russon,
L. M.; Lakshman, M. K. Angew. Chem., Int. Ed. 2004, 43, 6372. (e) Lakshman,
M. K.; Gunda, P.; Pardhan, P. J. Org. Chem. 2005, 73, 10329. (f) Liu, J. Q.;
Robins, M. J. Org. Lett. 2005, 7, 1149. (g) Liu, J. Q.; Robins, M. J. Org. Lett.
2004, 6, 3421. (h) Kang, F. A.; Sui, Z.; Murray, W. V. J. Am. Chem. Soc.
2008, 130, 11300.
Purine bases and purine nucleoside derivatives play pro-
minent roles in biology, biochemistry, and pharmaceutical
areas.1 Purine analogues with various substituents at C6
have received great attention due to their high cytotoxicity,
antitumor activity, and broad spectrum of biological activities.2
6-Arylpurine bases and their nucleosides are of particular
importance due to anti-HCV, cytostatic, and antimycobacterial
(7) (a) Gundersen, L. L.; Langli, G.; Rise, F. Tetrahedron Lett. 1995, 36,
1945. (b) Gundersen, L. L.; Langli, G.; Rise, F. Tetrahedron 1996, 52, 5625.
ꢀ
ꢁꢀ
(c) Havelkova, M.; Dvorak, D.; Hocek, M. Tetrahedron 2002, 58, 7431.
(8) Brændvang, M.; Gundersen, L. L. Bioorg. Med. Chem. 2005, 13, 6360.
ꢀ
(9) Furstner, A.; Leitner, A.; Mendez, M.; Krause, H. J. Am. Chem. Soc.
2002, 124, 13856.
(10) (a) Qu, G. R.; Xia, R.; Yang, X. N.; Li, J. G.; Wang, D. C.; Guo,
H. M. J. Org. Chem. 2008, 73, 2416. (b) Qu, G. R.; Zhao, L.; Wang, D. C.;
Wu, J.; Guo, H. M. Green Chem. 2008, 10, 287. (c) Qu, G. R.; Mao, Z. J.; Niu,
H. Y.; Wang, D. C.; Xia, C.; Guo, H. M. Org. Lett. 2009, 11, 1745. (d) Qu.,
G. R.; Wu., J.; Wu., Y. Y.; Zhang., F.; Guo, H. M. Green Chem. 2009, 11,
760. (e) Guo, H. M.; Wu, Y. Y.; Niu, H. Y.; Wang, D. C.; Qu, G. R. J. Org.
Chem. 2010, 75, 3863. (f) Guo, H. M.; Wu, J.; Niu, H. Y.; Wang, D. C.;
Zhang, F.; Qu, G. R. Bioorg. Med. Chem. Lett. 2010, 20, 3098.
(11) (a) Pal, M.; Batchu, V. R.; Parasuraman, K.; Yeleswarapu, K. R.
J. Org. Chem. 2003, 68, 6806. (b) Pal, M.; Batchu, V. R.; Dager, I.; Swamy,
N. K.; Padakanti, S. J. Org. Chem. 2005, 70, 2376. (c) Pal, M.; Batchu, V. R.;
Khanna, S.; Yeleswarapu, K. R. Tetrahedron 2002, 58, 9933. (d) Kodimuthali,
A.; Nishad, T. C.; Prasunamba, P. L.; Pal, M. Tetrahedron Lett. 2009, 50,
354.
(1) Legraverend, M.; Grierson, D. S. Bioorg. Med. Chem. 2006, 14, 3987.
(2) (a) Cocuzza, A. J.; Chidester, D. R.; Culp, S.; Fitzgerald, L.; Gilligan,
P. Bioorg. Med. Chem. Lett. 1999, 9, 1063. (b) Verdugo, D. E.; Cancilla,
M. T.; Ge, X.; Gray, N. S.; Chang, Y.-T.; Schultz, P. G.; Negishi, M.; Leary,
J. A.; Bertozzi, C. R. J. Med. Chem. 2001, 44, 2683.
ꢀ
ꢁꢀ
ꢀ
(3) (a) Hocek, M.; Holy, A; Votruba, I; Dvorakova, H. J. Med. Chem.
2000, 43, 1817. (b) Gundersen, L. L; Nissen-Meyer, J.; Rise, F.; Spilsberg, B.
J. Med. Chem. 2002, 45, 1383. (c) Bakkestuen, A. K.; Gundersen, L. L.;
ꢁ
Utenova, B. T. J. Med. Chem. 2005, 48, 2710. (d) Hocek, M.; Naus, P.; Pohl,
R; Votruba, I.; Furman, P. A.; Tharnish, P. M.; Otto, M. J. J. Med. Chem.
2005, 48, 5869.
6016 J. Org. Chem. 2010, 75, 6016–6018
Published on Web 08/10/2010
DOI: 10.1021/jo1010334
r
2010 American Chemical Society